Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$35.41
-1.97%
Mkt Cap $570.78M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
Implied Upside
+96.8%
Consensus $69.67 vs current $35.41
NASDAQ·Healthcare·Biotechnology
$35.41
-1.97%
Mkt Cap $570.78M
Buy
5
Hold
0
Sell
0
Price Target (15 analysts)
$69.67
Range $69.00 – $70.00
+96.8%
Consensus $69.67 vs current $35.41